During the past decade, Cardiovascular Research, Karolinska Institue conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Research, Karolinska Institue" are "Hypertension" (2 trials). Many other conditions were trialed in "Cardiovascular Research, Karolinska Institue" in a lesser frequency.

Most popular intervention types in "Cardiovascular Research, Karolinska Institue" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials) and "Darusentan Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Research, Karolinska Institue" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Research, Karolinska Institue". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiovascular Research, Karolinska Institue, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Research, Karolinska Institue, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".